APA

Breij E. C. W., de Goeij B. E. C. G., Verploegen S., Schuurhuis D. H., Amirkhosravi A., Francis J., Miller V. B., Houtkamp M., Bleeker W. K., Satijn D. & Parren P. W. H. I. (20140422). An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors. : Cancer research.

Chicago

Breij Esther C W, de Goeij Bart E C G, Verploegen Sandra, Schuurhuis Danita H, Amirkhosravi Ali, Francis John, Miller Vibeke Breinholt, Houtkamp Mischa, Bleeker Wim K, Satijn David and Parren Paul W H I. 20140422. An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors. : Cancer research.

Harvard

Breij E. C. W., de Goeij B. E. C. G., Verploegen S., Schuurhuis D. H., Amirkhosravi A., Francis J., Miller V. B., Houtkamp M., Bleeker W. K., Satijn D. and Parren P. W. H. I. (20140422). An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors. : Cancer research.

MLA

Breij Esther C W, de Goeij Bart E C G, Verploegen Sandra, Schuurhuis Danita H, Amirkhosravi Ali, Francis John, Miller Vibeke Breinholt, Houtkamp Mischa, Bleeker Wim K, Satijn David and Parren Paul W H I. An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors. : Cancer research. 20140422.